🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Antiepileptic drugs (AEDs) are the main treatment for epilepsy; however, on...
Status
Terminated
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00698581
Treatments Being Tested
This study will estimate how fast two antiepileptic drugs (Levetiracetam an...
Status
Completed
Location
Ep0074 001
Start Date
2015-11
Trial ID
NCT02602860
Treatments Being Tested
This trial will evaluate the efficacy and safety of brivaracetam (at doses ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00175929
Treatments Being Tested
To evaluate if Brivaracetam (BRV) influences the psychomotor and cognitive ...
Status
Completed
Location
Multiple Locations
Start Date
2012-09
Trial ID
NCT01710670
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of brivaracetam (BRV) ...
Status
Completed
Location
Ep0083 905
Start Date
2017-08-22
Trial ID
NCT03083665
Treatments Being Tested
This is a multicenter, open-label, 4-arm, randomized, parallel-group study ...
Status
Completed
Location
001
Start Date
2011-08
Trial ID
NCT01405508
Treatments Being Tested
The primary objective of this study is to compare the efficacy of Brivarace...
Status
Terminated
Location
3
Start Date
2014-03
Trial ID
NCT02088957
The purpose of the study is to assess the pharmacokinetics, safety, and tol...
Status
Completed
Location
Ep0101 101
Start Date
2021-05-19
Trial ID
NCT04882540
Treatments Being Tested
This trial, evaluating the long-term safety and tolerability of brivaraceta...
Status
Completed
Location
N01199 1051
Start Date
2006-01
Trial ID
NCT00150800
Treatments Being Tested
This trial, evaluating the long-term safety and tolerability of brivaraceta...
Status
Completed
Location
935
Start Date
2005-09
Trial ID
NCT00175916
Treatments Being Tested